( in Million)
Particulars
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Audited / UnAudited
UnAudited
Audited
Audited
Audited
Net Sales
572.97
515.79
732.97
460.48
Total Expenditure
561.53
503.68
742.54
472
PBIDT (Excl OI)
11.44
12.11
-9.56
-11.52
Other Income
10.15
17.08
20.01
7.65
Operating Profit
21.58
29.19
10.44
-3.87
Interest
14.84
11.66
16.66
15.2
Exceptional Items
NA
NA
NA
NA
Depreciation
3.81
3.75
4.3
4.16
Profit Before Tax
2.93
13.78
-10.52
-23.23
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
0.90
10.78
7.3
-12.33
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
0.90
10.78
7.3
-12.33
Minority Interest
-0.96
-0.32
2.24
-1.03
Shares of Associates
0.03
-0.08
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
-0.06
10.46
9.57
-13.44
Equity Capital
31.17
31.17
31.17
31.17
Face Value (IN RS)
10
10
10
10
Calculated EPS
-0.01
3.35
3.07
-4.31
Calculated EPS (Annualised)
-0.07
13.42
12.28
-17.24
No of Public Share Holdings
1157941
1157941
1158022
1158562
% of Public Share Holdings
37.15
37.15
37.15
37.17
PBIDTM% (Excl OI)
1.99
2.34
-1.30
-2.50